Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway.
Saved in:
| Title: | Liraglutide attenuates aluminum chloride-induced Alzheimer's disease in rats by modulating the oxLDL/LPA/LPAR1 pathway. |
|---|---|
| Authors: | Abo El-Magd NF; Biochemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. dr.nada.fawzy@gmail.com., Ramadan NM; Clinical Pharmacology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt., Eraky SM; Biochemistry Department, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt. |
| Source: | Communications biology [Commun Biol] 2026 Feb 11; Vol. 9 (1), pp. 262. Date of Electronic Publication: 2026 Feb 11. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
